Why Pfizer Is Looking East for Its Next Generation of Cancer Drugs
1. Pfizer has committed $650 million upfront in a collaboration with Innovent Biologics that could ultimately reach $10.5 billion in ...
Tag: Cancer drugs
The majority of FDA-approved drug trials recruit from low- and middle-income countries
1. This study found that a high proportion of Food and Drug Administration (FDA) drug trials recruit participants from low- ...
